Company profile for Apic Bio

Apic Bio

NEW Drugs in Dev: 1

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

pharmacompass-2-2026-02-09

Contact Supplier

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

5 News #PharmaBuzz

media
5 News #PharmaBuzz

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Apic Bio is committed to finding cures for patients with genetic diseases. The company is a spin-off from the University of Massachusetts Medical School (UMMS) and is based upon nearly 30 years of gene therapy research by Apic’s scientific founders. Apic is developing best-in-class treatment options for rare, devastating neurological and liver diseases. Its current pipeline focuses on new and effective treatments for Alpha-1...

Apic Bio is committed to finding cures for patients with genetic diseases. The company is a spin-off from the University of Massachusetts Medical School (UMMS) and is based upon nearly 30 years of gene therapy research by Apic’s scientific founders. Apic is developing best-in-class treatment options for rare, devastating neurological and liver diseases. Its current pipeline focuses on new and effective treatments for Alpha-1 Antitrypsin Deficiency (Alpha-1, or AATD) and genetic Amyotrophic Lateral Sclerosis (ALS.)

Clinical OutsourcingClinical Outsourcing

Not Confirmed

Not Confirmed

03-04 March, 2026

Copthorne Tara Hotel, London Kensington, United Ki
Natural Product Expo W...Natural Product Expo West

Not Confirmed

Not Confirmed

03-06 March, 2026

California, U.S.A
Natural Products ExpoNatural Products Expo

Not Confirmed

Not Confirmed

03-06 March, 2026

California, U.S.A

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

United_States_of_America Flag

Country

Country

U.S.A

Address

Address

700 Main Street, North Cambridge, MA, 02139

Telephone

Telephone

Email

enquiries@pharmacompass.com

Client Website

Website

https://apic-bio.com/

Linkedin

https://www.linkedin.com/company/apic-bio-inc

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

uniQure and Apic Bio enter into global licensing agreement for APB-102

31 Jan 2023

// GLOBENEWSWIRE

Apic Bio gets FDA Fast Track Designation for APB-102 for Patients with SOD1 ALS

29 Jul 2021

// BUSINESSWIRE

Apic Bio Announces FDA Clearance of IND App for Lead Gene Therapy APB-102

21 Apr 2021

// BUSINESSWIRE

Apic Bio Announces FDA Clearance of IND for Lead Gene Therapy APB-102

21 Apr 2021

// BUSINESSWIRE

Chutes & Ladders—Apic brings on Solid Bio vet Quiroz to chief medical role

28 Aug 2020

// K. Blankenship FIERCEBIOTECH

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search